nialamide has been researched along with Parkinson Disease in 5 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmutzler, F | 1 |
| Eichhorn, A | 1 |
| Petelin, LS | 1 |
| Tret'iakova, KA | 1 |
| Pigarev, VA | 1 |
| Romenskaia, LK | 1 |
| Farnebo, LO | 1 |
| Fuxe, K | 1 |
| Goldstein, M | 1 |
| Hamberger, B | 1 |
| Ungerstedt, U | 1 |
| De la Torre, JC | 1 |
| Mullan, S | 1 |
| Dandiya, PC | 1 |
| Bhargava, LP | 1 |
1 review available for nialamide and Parkinson Disease
| Article | Year |
|---|---|
[Antiparkinson agents. 50].
Topics: Atropine; Dihydroxyphenylalanine; Diphenhydramine; Histamine H1 Antagonists; Humans; Mephenesin; Mon | 1970 |
4 other studies available for nialamide and Parkinson Disease
| Article | Year |
|---|---|
[Pathochemical bases for the treatment of parkinsonism].
Topics: Adult; Aged; Antiparkinson Agents; Catecholamines; Dihydroxyphenylalanine; Female; Humans; Male; Mid | 1971 |
Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease.
Topics: Amantadine; Animals; Catecholamines; Central Nervous System; Dopamine; Electrocoagulation; Hindlimb; | 1971 |
Experimental evaluation of L-dopa penetration in brain.
Topics: Blood-Brain Barrier; Brain; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Humans | 1971 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine | 1968 |